203 related articles for article (PubMed ID: 16807357)
1. Translocation of endothelial nitric-oxide synthase involves a ternary complex with caveolin-1 and NOSTRIN.
Schilling K; Opitz N; Wiesenthal A; Oess S; Tikkanen R; Müller-Esterl W; Icking A
Mol Biol Cell; 2006 Sep; 17(9):3870-80. PubMed ID: 16807357
[TBL] [Abstract][Full Text] [Related]
2. NOSTRIN functions as a homotrimeric adaptor protein facilitating internalization of eNOS.
Icking A; Matt S; Opitz N; Wiesenthal A; Müller-Esterl W; Schilling K
J Cell Sci; 2005 Nov; 118(Pt 21):5059-69. PubMed ID: 16234328
[TBL] [Abstract][Full Text] [Related]
3. NOSTRIN: a protein modulating nitric oxide release and subcellular distribution of endothelial nitric oxide synthase.
Zimmermann K; Opitz N; Dedio J; Renne C; Muller-Esterl W; Oess S
Proc Natl Acad Sci U S A; 2002 Dec; 99(26):17167-72. PubMed ID: 12446846
[TBL] [Abstract][Full Text] [Related]
4. Increased gene and protein expression of the novel eNOS regulatory protein NOSTRIN and a variant in alcoholic hepatitis.
Mookerjee RP; Wiesenthal A; Icking A; Hodges SJ; Davies NA; Schilling K; Sen S; Williams R; Novelli M; Müller-Esterl W; Jalan R
Gastroenterology; 2007 Jun; 132(7):2533-41. PubMed ID: 17570224
[TBL] [Abstract][Full Text] [Related]
5. Platelet-endothelial cell adhesion molecule-1 regulates endothelial NO synthase activity and localization through signal transducers and activators of transcription 3-dependent NOSTRIN expression.
McCormick ME; Goel R; Fulton D; Oess S; Newman D; Tzima E
Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):643-9. PubMed ID: 21183735
[TBL] [Abstract][Full Text] [Related]
6. Candesartan cilexetil ameliorates NOSTRIN-NO dependent portal hypertension in cirrhosis and ACLF.
Vairappan B; Wright G; M S; Ravikumar TS
Eur J Pharmacol; 2023 Nov; 958():176010. PubMed ID: 37634841
[TBL] [Abstract][Full Text] [Related]
7. Changes in human umbilical vein endothelial cells induced by endothelial nitric oxide synthase traffic inducer.
Xu XY; Pang WJ; Wen ZN; Xiang WP
J Huazhong Univ Sci Technolog Med Sci; 2013 Apr; 33(2):272-276. PubMed ID: 23592143
[TBL] [Abstract][Full Text] [Related]
8. Nitric-oxide synthase trafficking inducer is a pleiotropic regulator of endothelial cell function and signaling.
Chakraborty S; Ain R
J Biol Chem; 2017 Apr; 292(16):6600-6620. PubMed ID: 28235804
[TBL] [Abstract][Full Text] [Related]
9. Regulation of endothelial nitric oxide synthase activity by protein-protein interaction.
Su Y
Curr Pharm Des; 2014; 20(22):3514-20. PubMed ID: 24180383
[TBL] [Abstract][Full Text] [Related]
10. A novel role for caveolin-1 in regulating endothelial nitric oxide synthase activation in response to H2O2 and shear stress.
Tian J; Hou Y; Lu Q; Wiseman DA; Vasconcelos Fonsesca F; Elms S; Fulton DJ; Black SM
Free Radic Biol Med; 2010 Jul; 49(2):159-70. PubMed ID: 20353820
[TBL] [Abstract][Full Text] [Related]
11. Endothelial nitric oxide synthase is segregated from caveolin-1 and localizes to the leading edge of migrating cells.
Bulotta S; Cerullo A; Barsacchi R; De Palma C; Rotiroti D; Clementi E; Borgese N
Exp Cell Res; 2006 Apr; 312(6):877-89. PubMed ID: 16427620
[TBL] [Abstract][Full Text] [Related]
12. The trafficking/interaction of eNOS and caveolin-1 induced by insulin modulates endothelial nitric oxide production.
Wang H; Wang AX; Liu Z; Chai W; Barrett EJ
Mol Endocrinol; 2009 Oct; 23(10):1613-23. PubMed ID: 19608646
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide-dependent Src activation and resultant caveolin-1 phosphorylation promote eNOS/caveolin-1 binding and eNOS inhibition.
Chen Z; Bakhshi FR; Shajahan AN; Sharma T; Mao M; Trane A; Bernatchez P; van Nieuw Amerongen GP; Bonini MG; Skidgel RA; Malik AB; Minshall RD
Mol Biol Cell; 2012 Apr; 23(7):1388-98. PubMed ID: 22323292
[TBL] [Abstract][Full Text] [Related]
14. Caveolin-1 mediates endotoxin inhibition of endothelin-1-induced endothelial nitric oxide synthase activity in liver sinusoidal endothelial cells.
Kwok W; Lee SH; Culberson C; Korneszczuk K; Clemens MG
Am J Physiol Gastrointest Liver Physiol; 2009 Nov; 297(5):G930-9. PubMed ID: 20501440
[TBL] [Abstract][Full Text] [Related]
15. Insulin and IGF-I phosphorylate eNOS in HUVECs by a caveolin-1 dependent mechanism.
Repetto S; Salani B; Maggi D; Cordera R
Biochem Biophys Res Commun; 2005 Nov; 337(3):849-52. PubMed ID: 16225848
[TBL] [Abstract][Full Text] [Related]
16. Amlodipine increases endothelial nitric oxide release by modulating binding of native eNOS protein complex to caveolin-1.
Sharma A; Trane A; Yu C; Jasmin JF; Bernatchez P
Eur J Pharmacol; 2011 Jun; 659(2-3):206-12. PubMed ID: 21463621
[TBL] [Abstract][Full Text] [Related]
17. NOSIP, a novel modulator of endothelial nitric oxide synthase activity.
Dedio J; König P; Wohlfart P; Schroeder C; Kummer W; Müller-Esterl W
FASEB J; 2001 Jan; 15(1):79-89. PubMed ID: 11149895
[TBL] [Abstract][Full Text] [Related]
18. Rho-kinase activation contributes to Lps-induced impairment of endothelial nitric oxide synthase activation by endothelin-1 in cultured hepatic sinusoidal endothelial cells.
Kwok W; Clemens MG
Shock; 2014 Dec; 42(6):554-61. PubMed ID: 25243430
[TBL] [Abstract][Full Text] [Related]
19. Regulation of endothelial nitric oxide synthase by the actin cytoskeleton.
Su Y; Edwards-Bennett S; Bubb MR; Block ER
Am J Physiol Cell Physiol; 2003 Jun; 284(6):C1542-9. PubMed ID: 12734108
[TBL] [Abstract][Full Text] [Related]
20. Aliskiren attenuates the effects of interleukin-6 on endothelial nitric oxide synthase and caveolin-1 in human aortic endothelial cells.
Hung MJ; Kao YC; Mao CT; Chen TH; Chen WS
Nitric Oxide; 2016 Dec; 61():45-54. PubMed ID: 27773804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
